Trial intelligence / Profile preview

PRP injection after intramedullary fixation for tibial shaft fracture union

IRCT20251213068298N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
May 2026
Countries
1
01

Overview

Phase 3, double-blind trial of platelet-rich plasma in tibial diaphyseal fracture (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Enhancement of fracture union. Started May 2026; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

tibial diaphyseal fracture

Beyond the preview

Go deeper on IRCT20251213068298N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251213068298N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call